Clinical Trial

Remote Intervention to Prevent Overdose

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This Type 1 hybrid effectiveness-implementation randomized controlled trial, A Remote Intervention to Prevent Overdose among People who Use Stimulants and/or Opioids, aims to address the United States opioid crisis driven by fentanyl and other synthetic opioids by reducing overdose rates. It is supported by and included in the HEAL Initiative. This study would be the first national, fully remote trial to assess the impact of remote education on overdose outcomes, using a novel 2x2 design crossing remote education with remote access support. This research will inform scalability around remote education programs to address the nation's opioid overdose crisis.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-09 -> 2027-11 2026-05-15
minor Completion pushed: 2027-09 -> 2027-11 2026-05-15
Trial Details
NCT Number NCT07128485
Lead Sponsor University of Alabama at Birmingham
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Accidental Overdose of Opiate
Enrollment 100 participants
Start Date 2027-01
Primary Completion 2027-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-12